摘要
目的:构建适于原核表达的重组蛋白FasL表达载体,并进行重组蛋白的表达纯化及抗肿瘤活性分析。方法:获得人FasL cDNA全序列,将其分段设计引物,通过重叠PCR获得FasL基因。构建pGEX-5X-1/FasL表达载体。转化大肠杆菌BL21(DE3),IPTG诱导表达,GST柱纯化。采用MTT比色法、流式细胞法检测融合蛋白对胃癌细胞的作用。结果:通过重叠PCR获得了编码正确氨基酸序列的目的基因。表达的目的蛋白表达量占菌体总蛋白的30%以上。纯化后,蛋白纯度达95%以上。MTT比色法与流式细胞技术均表明纯化的融合蛋白能抑制胃癌细胞株BGC823和MGC803的生长,诱导其调亡增加。结论:重组蛋白FasL表达载体的成功构建、表达、纯化及活性分析,为进一步的抗肿瘤功能研究奠定了基础。
Objective: To construct a vector expressing FasL gene and to investigate the influences of FasL on the growth of BGC823 and MGC803 cells. Methods: The FasL gene was obtained through overlapping PCR and then was inserted into vector pGEX-5X-1 and expressed efficiently in E.coli BL21 (DE3). The expressed products were purified through GST resin column. The effect of recombined-protein on gastric cancer cell lines BGC823 and MGC803 was detected by MTT colorimetric and flow cytometry. Results: The proteins were expressed mainly as secretion with the yield of more than 30% of total bacterial proteins. After purification, the purity of the proteins was all more than 95%. The MTT-F colorimetric and flow cytometry suggested that the purified protein could inhibit the growth of BGC823 and MGC803 cell lines through inducing tumor cell apoptosis. Conclusion: The construction of vector expressing FasL, the purification of FasL gene and analysis of its anti-tumor activities provide the foundation for further study.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2009年第18期1067-1070,共4页
Chinese Journal of Clinical Oncology
基金
福建省自然科学基金资助(编号:C0710046)~~